The Valley Desk

NCT03226899 · Interventional trial

A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment

Overall registry status Terminated

Phase 4

Conditions Chronic Kidney Disease (CKD), Gout

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov